The International Society of Amyloidosis (ISA) and Pfizer are collaborating to offer a new competitive grant opportunity focused on supporting fellowships in Cardiac Transthyretin Amyloid (ATTR).
The goal of this program is to train physicians to recognize and diagnose cardiac ATTR amyloidosis.
Unlike previous Cardiac Transthyretin Amyloid (ATTR) fellowships, the 2023-2024 fellowships will be structured to support experienced amyloidosis centers in hosting fellows from regions around the globe where a high level of expertise in cardiac amyloidosis is lacking. Fellows are expected to return to their home institutions to provide expertise and mentoring on cardiac ATTR amyloidosis in their regions.
This is a program based (not project based) grant to identify Host Institutions for Cardiac Transthyretin Amyloid Fellows, It is our intent to support institutions with fellowship programs for Cardiologists that have a strong focus on clinical practice, research, and education to further the understanding of Cardiac Transthyretin Amyloid (ATTR). The selected Host Institutions will be paired with a Fellow selected by the ISA.
Full Proposal Deadline: Jan. 5, 2023
Geographic Scope • Global
To be eligible:
• Do not include the name of the potential fellow(s) in application materials. This grant will be awarded to an institution, not an individual.
• Institutions with fellowship programs that include independent research and a strong mentoring program.
o Examples of independent research include observational studies and outcomes research studies where the primary focus is the scientific understanding of disease; use of screening tools and their impact on improvement of patient health.
- Examples of research that would not be eligible include research involving the study and/or evaluation of any pharmaceutical product and basic science and/or fundamental research (in animal model, in-vitro, etc.).
o Examples of clinical training include educational time with an interdisciplinary team in review of case examples and relevant didactic training as well as use of tools for improvement in patient health for specific therapeutic areas or conditions.
• Grant funding is available to support one fellow for a year at up to $125,000. The budget may only include salary and support of the fellow benefits.